| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD011767 |
| P50 | author | France Légaré | Q28324521 |
| Yemisi Takwoingi | Q30004015 | ||
| Alexis F. Turgeon | Q52601875 | ||
| P2093 | author name string | Sylvie Langlois | |
| François Rousseau | |||
| Yves Giguère | |||
| William Witteman | |||
| Jonatan Blais | |||
| Carmen Lindsay | |||
| Mylène Badeau | |||
| P2860 | cites work | A review of trisomy X (47,XXX) | Q21093168 |
| Update on Procedure-Related Risks for Prenatal Diagnosis Techniques | Q22241937 | ||
| Decision Making Following a Prenatal Diagnosis of Down Syndrome: An Integrative Review | Q22242353 | ||
| Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012 | Q22242878 | ||
| Clinical practice. The care of children with Down syndrome | Q22252697 | ||
| Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006 | Q22252926 | ||
| Second trimester serum tests for Down's Syndrome screening | Q22252964 | ||
| Neurocognitive outcomes of individuals with a sex chromosome trisomy: XXX, XYY, or XXY: a systematic review | Q24649106 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies | Q27861031 | ||
| Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA | Q28729130 | ||
| An integrated semiconductor device enabling non-optical genome sequencing | Q29617149 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| 47,XYY syndrome: clinical phenotype and timing of ascertainment | Q33900758 | ||
| Diagnosis and mortality in 47,XYY persons: a registry study. | Q33930723 | ||
| Prenatal screening for fetal aneuploidy in singleton pregnancies | Q33958921 | ||
| Parental origin of normal X chromosomes in Turner syndrome patients with various karyotypes: implications for the mechanism leading to generation of a 45,X karyotype | Q34147611 | ||
| Circulating cell-free DNA levels increase variably following chorionic villus sampling. | Q34250874 | ||
| Caring for children with Down syndrome and their families | Q34251184 | ||
| From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges | Q34286705 | ||
| The trisomy 18 syndrome | Q34307500 | ||
| Clinical review: Klinefelter syndrome--a clinical update. | Q34309526 | ||
| High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. | Q34340492 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). | Q34480542 | ||
| Clinical practice. Prenatal screening for aneuploidy | Q34986134 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| Circulating fetal DNA: its origin and diagnostic potential-a review | Q35699978 | ||
| Down syndrome, Turner syndrome, and Klinefelter syndrome: primary care throughout the life span | Q35872367 | ||
| Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe | Q35899367 | ||
| Survival among people with Down syndrome: a nationwide population-based study in Denmark | Q35939857 | ||
| How much do family physicians involve pregnant women in decisions about prenatal screening for Down syndrome? | Q82256930 | ||
| Cardiovascular abnormalities in Down's syndrome: spectrum, management and survival over 22 years | Q84749434 | ||
| Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 | ||
| Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening | Q86607373 | ||
| Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications | Q36424760 | ||
| Prenatal screening for fetal aneuploidy | Q36754874 | ||
| Mid-trimester amniocentesis fetal loss rate | Q36876576 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| The population prevalence of Down's syndrome in England and Wales in 2011. | Q37102148 | ||
| Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation | Q37104743 | ||
| Decisional needs assessment regarding Down syndrome prenatal testing: a systematic review of the perceptions of women, their partners and health professionals | Q37355136 | ||
| Commercial landscape of noninvasive prenatal testing in the United States | Q37504505 | ||
| Prenatal sonographic features of fetuses in trisomy 13 pregnancies (I). | Q37606822 | ||
| Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies | Q37933548 | ||
| Fertility, pregnancy, and medical management of Turner syndrome in the reproductive years | Q38047422 | ||
| Non-invasive prenatal testing for aneuploidy: current status and future prospects | Q38114375 | ||
| Quantification of free fetal DNA in multiple pregnancies and relationship with chorionicity | Q39727263 | ||
| Prenatal screening for Down syndrome: a survey of willingness in women and family physicians to engage in shared decision-making | Q42687572 | ||
| Antenatal screening for Down syndrome: a quantitative demonstration of the improvements over the past 20 years | Q43892705 | ||
| Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures | Q44997824 | ||
| SURUSS in perspective | Q46653619 | ||
| Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis | Q46945516 | ||
| Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing | Q47427812 | ||
| DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations | Q47764889 | ||
| Down syndrome: a study of chromosomal mosaicism | Q47797279 | ||
| Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies | Q50146668 | ||
| ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. | Q50310312 | ||
| Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction. | Q51114145 | ||
| Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. | Q51866446 | ||
| Mortality and incidence in women with 47,XXX and variants. | Q53180061 | ||
| Use of array genomic hybridization technology in prenatal diagnosis in Canada. | Q54334271 | ||
| Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. | Q54688617 | ||
| The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. | Q54708648 | ||
| Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. | Q55042216 | ||
| Turner's Syndrome | Q56083756 | ||
| Congenital heart disease in patients with Turner’s syndrome | Q56083757 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Mortality in Women with Turner Syndrome in Great Britain: A National Cohort Study | Q59291467 | ||
| Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years | Q61850578 | ||
| Quantitative variation analysis of fetal DNA in maternal plasma samples collected before and after amniocentesis | Q61853268 | ||
| Turner's syndrome | Q71801551 | ||
| Cell-free fetal DNA in maternal circulation after amniocentesis | Q73552686 | ||
| A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations | Q74545500 | ||
| Prospective experience with integrated prenatal screening and first trimester combined screening for trisomy 21 in a large Canadian urban center | Q79619283 | ||
| ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy | Q80138010 | ||
| P921 | main subject | human pregnancy | Q11995 |
| pregnant person | Q104720811 | ||
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women |
Search more.